REGN vs AMGN
REGN and AMGN side by side — valuation & fundamentals (public data).
Key statistics
| Metric | REGNREGENERON PHARMACEUTICALS, INC. | AMGNAmgen Inc. |
|---|---|---|
| Market cap | — | $203.14B |
| P/E (TTM) | 19.1 | 23.3 |
| P/B | — | 17.38 |
| P/S | — | 5.5x |
| Dividend yield | — | 2.52% |
| Revenue | $15.53B(TTM) | $38.09B(TTM) |
| Revenue growth (YoY) | 1.0% | 10.0% |
| Net income | $4.33B(TTM) | $8.74B(TTM) |
| Earnings growth (YoY) | 2.1% | 88.5% |
| EPS, diluted | $40.41(TTM) | $16.10(TTM) |
| EBIT margin | 24.9% | 24.7% |
| ROE | 14.2% | 66.0% |
| ROIC | 9.4% | 15.1% |
| 1y total return | +35.0% | +40.3% |
Figures from SEC filings · for reference only · not investment advice
$10,000 투자 성장: REGN vs AMGN
| 지표 | REGN | AMGN |
|---|---|---|
| 최종 가치 | $21.4K | $33.5K |
| 총수익률 | +113.7% | +235.2% |
| CAGR | +7.6% | +12.4% |
| 변동성 | 32.1% | 25.0% |
| 샤프 | 0.26 | 0.43 |
| 소르티노 | 0.38 | 0.63 |
| 최대 낙폭 | -59.7% | -24.9% |
공통 거래일 2600일 기준, 2016-05-12 → 2026-09-15 · 무위험수익률 4.11% (현재 단기 국채 금리, 고정 적용)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)